Please log in to see the full text of this API!
Fluvastatin sodium
-
Synonyms:
SRI-62320, XU-62-320, XU-620
-
ATC:
C10AA04
-
Use:
Lorem
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:433.46 g/mol
-
CAS-RN:93957-55-2
-
InChI Key:ZGGHKIMDNBDHJB-NRFPMOEYSA-M
-
InChI:InChI=1S/C24H26FNO4.Na/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30;/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30);/q;+1/p-1/b12-11+;/t18-,19-;/m1./s1
Derivatives
free acid
-
Use:
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:411.47 g/mol
-
CAS-RN:93957-54-1
Substances Referenced in Synthesis Path
| CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
| 1694-31-1 |
C8H14O3 |
tert-butyl acetoacetate |
Butanoic acid, 3-oxo-, 1,1-dimethylethyl ester |
| 129332-29-2 |
C28H34FNO4 |
tert-butyl (±)-erythro-(E)-7-[3-(4-fluorophenyl)-1-isopropylindol-2-yl]-3,5-dihydroxyhept-6-enoate |
6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, 1,1-dimethylethyl ester, [R*,S*-(E)]-(.+-.)- |
|
C28H32FNO4 |
tert-butyl (±)-(E)-7-[3-(4-fluorophenyl)-1-isopropylindol-2-yl]-5-hydroxy-3-oxohept-6-enoate |
|
| 456-04-2 |
C8H6ClFO |
α-chloro-p-fluoroacetophenone |
Ethanone, 2-chloro-1-(4-fluorophenyl)- |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
| Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
| Country |
Trade Name |
Vendor |
Annotation |
| D |
Lorem |
Lorem
|
|
| Lorem |
Lorem
|
|
| F |
Lorem |
Lorem
|
|
| Lorem |
Lorem
|
|
| GB |
Lorem |
Lorem
|
|
| I |
Lorem |
Lorem
|
|
| Lorem |
Lorem
|
|
| Lorem |
Lorem
|
|
| J |
Lorem |
Lorem
Lorem
|
|
| USA |
Lorem |
Lorem
|
|
(wfm = withdrawn from market)
Formulations
- Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumy
References
-
- a US 9 999 999 (Sandoz; 11.10.1994; appl. 24.11.1993; USA-prior. 22.11.1982, 4.11.1983, 4.3.1985, 11.4.1985).
- WO 9 999 999 (Sandoz; appl. 18.11.1983; USA-prior. 22.11.1982, 4.11.1983, 4.3.1985).
- aa Walkup, R.E. et al.: Tetrahedron Lett. (TELEAY) 26 (18), 2155-2158 (1985).
- b EP 999 999 (Sandoz; appl. 11.10.1989; USA-prior. 13.10.1983, 22.5.1989).
-
review of synthetic processes:
- Repiç,O. et al.: Org. Process Res. Dev. (OPRDFK) 5, 519-527 (2001).
-
composition with improved storage stability:
- US 9 999 999 (Sandoz; 18.10.1994; appl. 22.12.1992; USA-prior. 12.12.1991).
-
oral pharmaceutical composition:
- EP 999 999 (Sandoz; appl. 8.12.1992; USA-prior. 12.12.1991).
-
combination with squalene synthase inhibitors:
- EP 999 999 (Squibb; appl. 16.10.1991; USA-prior. 19.10.1990).
- EP 999 999 (Squibb; appl. 1.6.1990; USA-prior. 5.6.1989).
-
combination with ACE inhibitors:
- EP 999 999 (Squibb; appl. 6.6.1991; USA-prior. 11.6.1990).
- EP 999 999 (Squibb; appl. 10.5.1991; USA-prior. 15.5.1990).
-
combination with niacin or probucol:
- EP 999 999 (Squibb; appl. 7.12.1982; USA-prior. 12.12.1988).
-
composition containing coenzyme Q10:
- US 9 999 999 (Merck & Co.; 12.6.1990; appl. 18.1.1989; USA-prior. 18.1.1989).
- US 9 999 999 (Merck & Co.; 29.5.1990; appl. 2.2.1989; USA-prior. 2.2.1989).
